About Us.
We strive to improve the lives of patients and humanity. Through our drug development programs, our goal is to acheive long-term well-being for patients, ensuring quality of life through Luxa's dedicated progress.
Focus Area.
Luxa Biotechnology's clinical trial plan for dry AMD treatment aims to prevent or reverse vision loss by implanting adult stem cell derived retinal pigment epithelial cells under the retina of the eye.
Press releases & Announcements.
Luxa Biotechnology LLC leads in the bio business with an open innovation strategy, focusing on cutting-edge technology and research. Explore the future of innovation with us.